Internal Reference Number: FOI_7530
Date Request Received: 08/11/2023 00:00:00
Date Request Replied To: 23/11/2023 00:00:00
This response was sent via: By Email
Request Summary: Request on Rare Diseases
Request Category: Companies
Question Number 1: In the past 12 months, how many patients have been admitted as inpatients for each of the following conditions* (primary or secondary diagnosis)? • Adult Onset Stills Disease (AOSD) – ICD10 code M06.1 • Juvenile Arthritis with Systemic Onset (SJIA) – ICD10 code M08.2 • Periodic Fever Syndromes including Familial Mediterranean Fever (FMF), Tumor Necrosis factor Associated Periodic Syndromes (TRAPS) or Melvonate Kinase Deficiency (MKD) – ICD10 code E85.0 • Cryoprin-associated Periodic Syndromes (CAPS) – ICD10 code not available *In case you do not treat any condition, please provide the name of the trust you refer these patients to. | |
Answer To Question 1: Please see our response to all parts of this FOI in the Excel spreadsheet provided. To accompany this answer to question 1 please also see the documents listed below: 11797 - FOI_7530 - Request on Rare Diseases FOR ISSUE.xlsx | |
Question Number 2: How many patients has your trust/health board treated with Anakinra (Kineret) in the past 12 months, for each of the following: • Any medical condition • Rheumatoid Arthritis • Adult Onset Stills Disease (AOSD) • Juvenile Arthritis with Systemic Onset (SJIA) • Periodic Fever Syndromes (FMF, TRAPS or MKD) • Cryoprin-associated Periodic Syndromes (CAPS) | |
Answer To Question 2: See attachment in Q1 for response | |
Question Number 3: How many patients has your trust/health board treated with Canakinumab (Ilaris) in the past 12 months, for each of the following: • Any medical condition • Adult Onset Stills Disease (AOSD) • Juvenile Arthritis with Systemic Onset (SJIA) • Periodic Fever Syndromes (FMF, TRAPS or MKD) • Cryoprin-associated Periodic Syndromes (CAPS) | |
Answer To Question 3: See attachment in Q1 for response | |
Question Number 4: How many patients has your trust/health board treated with Tocilizumab in the past 12 months, for each of the following: • Any medical condition • Adult Onset Stills Disease (AOSD) • Juvenile Arthritis with Systemic Onset (SJIA) • Periodic Fever Syndromes (FMF, TRAPS or MKD) • Cryoprin-associated Periodic Syndromes (CAPS) | |
Answer To Question 4: See attachment in Q1 for response | |
Question Number 5: How many patients has your trust/health board treated with Etanercept in the past 12 months, for each of the following: • Any medical condition • Adult Onset Stills Disease (AOSD) • Juvenile Arthritis with Systemic Onset (SJIA) • Periodic Fever Syndromes (FMF, TRAPS or MKD) • Cryoprin-associated Periodic Syndromes (CAPS) | |
Answer To Question 5: See attachment in Q1 for response | |
Please see Attachments: | |
To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.